Evaxion Biotech News

Evaxion Biotech Analyst Ratings

BenzingaAug 16 05:44 ET

HC Wainwright & Co. Reiterates Buy on Evaxion Biotech, Maintains $14 Price Target

BenzingaAug 16 05:43 ET

H.C. Wainwright Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsAug 15 11:31 ET

Buy Rating Affirmed for Evaxion Biotech on Strong Financials and Promising Clinical Trials

TipRanksAug 15 11:17 ET

Evaxion Biotech Analyst Ratings

BenzingaAug 1 08:32 ET

H.C. Wainwright Maintains Evaxion Biotech(EVAX.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsAug 1 06:33 ET

Evaxion Biotech Analyst Ratings

BenzingaJun 4 07:18 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evaxion Biotech (EVAX), 60 Degrees Pharmaceuticals, Inc. (SXTP) and Genprex (GNPX)

TipRanksApr 3 06:40 ET

Evaxion Biotech Analyst Ratings

BenzingaApr 2 11:41 ET

Evaxion Biotech Analyst Ratings

BenzingaMar 20 06:57 ET

Buy Rating Affirmed for Evaxion Biotech Amid AI-Driven Vaccine Development Milestones

TipRanksMar 20 06:31 ET

H.C. Wainwright Initiates Buy Rating on Evaxion Biotech for Its AI Tech Utilization

InvestingFeb 12 09:42 ET

Evaxion Biotech Analyst Ratings

BenzingaFeb 12 07:49 ET

Lake Street Cuts Price Target on Evaxion Biotech to $7 From $18, Maintains Buy Rating

MT NewswiresMar 31, 2023 09:37 ET

Lake Street Maintains Buy on Evaxion Biotech, Lowers Price Target to $7

BenzingaMar 31, 2023 09:28 ET

Lake Street Keeps Their Buy Rating on Evaxion Biotech (EVAX)

TipRanksMar 31, 2023 09:15 ET

Evaxion Biotech Analyst Ratings

Benzinga Analyst RatingsNov 17, 2022 08:36 ET

Oppenheimer Maintains Outperform on Evaxion Biotech, Lowers Price Target to $11

Benzinga Real-time NewsNov 17, 2022 08:36 ET

Evaxion Biotech Price Target Announced at $16.00/Share by Oppenheimer

Dow JonesJul 18, 2022 10:42 ET

Evaxion Biotech analyst ratings

Benzinga Analyst RatingsJul 18, 2022 10:34 ET